Goel, Ayush and Ray, Animesh (2022) Steroids in COVID-19: Tailor-Made or “One Size Fits All”? Advances in Respiratory Medicine, 90 (1). pp. 94-96. ISSN 2543-6031
![[thumbnail of arm-90-00011.pdf]](http://publish7promo.com/style/images/fileicons/text.png)
Text
arm-90-00011.pdf - Published Version
Download (134kB)
Official URL: https://doi.org/10.5603/ARM.a2022.0005
Abstract
Since the RECOVERY trial, steroids have endorsed by all Guideliness for treating moderate-severe COVID-19. The prescribed dose is 6mg dexamethasone or its equivalents for 10 days. However, in clinical practice, there are numerous occasions where the role of steroids cannot be extrapolated from current evidence: patients on immunosuppression, patients with persistent oxygen requirement after ten days of therapy, etc. We highlight the existing caveats and the need for further research and discussion.
| Item Type: | Article |
|---|---|
| Subjects: | Euro Archives > Medical Science |
| Depositing User: | Managing Editor |
| Date Deposited: | 02 Dec 2022 04:00 |
| Last Modified: | 18 Jun 2024 06:34 |
| URI: | http://publish7promo.com/id/eprint/663 |
Actions (login required)
- View Item